Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5′-phosphatase interaction with c-Abl
出版年份 2013 全文链接
标题
Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5′-phosphatase interaction with c-Abl
作者
关键词
c-Abl, Cell death, EndoC-βH1 cells, Imatinib mesilate, Insulin-producing cells, PIP<sub>3</sub> signalling, SHIP2
出版物
DIABETOLOGIA
Volume 56, Issue 6, Pages 1327-1338
出版商
Springer Nature
发表日期
2013-03-05
DOI
10.1007/s00125-013-2868-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of phosphodiesterases in the shaping of sub-plasma-membrane cAMP oscillations and pulsatile insulin secretion
- (2012) G. Tian et al. JOURNAL OF CELL SCIENCE
- Strategic combination therapy overcomes tyrosine kinase coactivation in adrenocortical carcinoma
- (2012) Chi-Iou Lin et al. SURGERY
- A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion
- (2011) Philippe Ravassard et al. JOURNAL OF CLINICAL INVESTIGATION
- Deletion of Pten in Pancreatic -Cells Protects Against Deficient -Cell Mass and Function in Mouse Models of Type 2 Diabetes
- (2010) L. Wang et al. DIABETES
- SHIP2 and its involvement in various diseases
- (2010) Akira Suwa et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Plasma Adiponectin Levels Are Markedly Elevated in Imatinib-Treated Chronic Myeloid Leukemia (CML) Patients: A Mechanism for Improved Insulin Sensitivity in Type 2 Diabetic CML Patients?
- (2010) Stephen Fitter et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Protein Tyrosine Kinase Inhibitor, Imatinib Mesylate (Gleevec), Improves Erectile and Vascular Function Secondary to a Reduction of Hyperglycemia in Diabetic Rats
- (2010) Serap Gur et al. Journal of Sexual Medicine
- Genetics, pathogenesis and clinical interventions in type 1 diabetes
- (2010) Jeffrey A. Bluestone et al. NATURE
- Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice
- (2010) Nicole M Agostino et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Specific Tyrosine Phosphorylations Mediate Signal-Dependent Stimulation of SHIP2 Inositol Phosphatase Activity, while the SH2 Domain Confers an Inhibitory Effect To Maintain the Basal Activity
- (2009) Nagendra K. Prasad et al. BIOCHEMISTRY
- Potential utility of small tyrosine kinase inhibitors in the treatment of diabetes
- (2009) Dariush Mokhtari et al. CLINICAL SCIENCE
- Imatinib Mesylate Reduces Endoplasmic Reticulum Stress and Induces Remission of Diabetes in db/db Mice
- (2009) M. S. Han et al. DIABETES
- Lack of β-catenin in early life induces abnormal glucose homeostasis in mice
- (2009) S. Dabernat et al. DIABETOLOGIA
- Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2)
- (2009) Z. Liu et al. DIABETOLOGIA
- Imatinib does not substantially modify the glycemic profile in patients with chronic myeloid leukaemia
- (2009) Stefania Mariani et al. LEUKEMIA RESEARCH
- Potential of Small Molecule Protein Tyrosine Kinase Inhibitors as Immunomodulators and Inhibitors of the Development of Diabetes
- (2009) Peter J. Little et al. TheScientificWorldJOURNAL
- Glucose-Induced Cyclic AMP Oscillations Regulate Pulsatile Insulin Secretion
- (2008) Oleg Dyachok et al. Cell Metabolism
- Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell Proliferation
- (2008) Zhengyu Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr–Abl transformed cells via the alteration of signaling complex and the receptor turnover
- (2008) A Koch et al. ONCOGENE
- Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice
- (2008) C. Louvet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imatinib mesylate improves insulin sensitivity and glucose disposal rates in rats fed a high-fat diet
- (2007) Robert Hägerkvist et al. CLINICAL SCIENCE
- Restoration of insulin sensitivity following treatment with imatinib mesylate (Gleevec) in non-diabetic patients with chronic myelogenic leukemia (CML)
- (2007) Apostolos Tsapas et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now